Fluidigm (Canada)

Recent papers from Fluidigm (Canada)

1. A Domain-Driven, Physics-Backed, Proximity-Informed AI Model for PVT Predictions—Part II: Differential Liberation Expansion and Viscosity TestsChemEngineering · 2026
2. A Domain-Driven, Physics-Backed, Proximity-Informed AI Model for PVT Predictions—Part I: Constant Composition ExpansionChemEngineering · 2026
3. Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in CanadaCurrent Oncology · 2025
4. The learning curve for the Shouldice Repair: a pilot analysis of post-training specialized surgeons at the Shouldice HospitalHernia · 2025
5. A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal CarcinomaCurrent Oncology · 2025
6. Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario PerspectiveCurrent Oncology · 2024
7. Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENsJAMA Oncology · 2024
8. Angiographic Safety and Efficacy of the ReSolv Flow-Diverting Stent in a Rabbit ModelInterventional Neuroradiology · 2024
9. Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndromeClinical and Translational Medicine · 2023
10. A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in CanadaCurrent Oncology · 2023
11. Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populationsInternational Journal of Infectious Diseases · 2023
12. How We Manage Patients with Indolent B-Cell Malignancies on Bruton’s Tyrosine Kinase Inhibitors: Practical Considerations for Nurses and PharmacistsCurrent Oncology · 2023
13. Management of Marginal Zone Lymphoma: A Canadian PerspectiveCurrent Oncology · 2023
14. Reagents for Mass CytometryChemical Reviews · 2023
15. Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome2022
16. Combined Targeting of the Glutathione and Thioredoxin Antioxidant Systems in Pancreatic CancerACS Pharmacology & Translational Science · 2022
17. Development of Multiplexed Bead-Based Immunoassays for Profiling Soluble Cytokines and CD163 Using Mass CytometryACS Measurement Science Au · 2022
18. A Canadian Perspective on the Treatment of Waldenström MacroglobulinemiaCurrent Oncology · 2022
19. Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian PerspectiveCurrent Oncology · 2022
20. Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13Patient · 2022